Skip to content

Efficiency of the guide extension catheter-facilitated Tip-in technique in the percutaneous recanalization of coronary total occlusion lesions (ECLIPSE)

Efficiency of the guide extension catheter-facilitated Tip-in technique in the percutaneous recanalization of coronary total occlusion lesions (ECLIPSE)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100021
Enrollment
Unknown
Registered
2025-04-02
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary chronic total occlusion

Interventions

Tip-in:guide extension catheter facilitated tip-in
control:wire externalization with RG3

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged 18 to 85; (2) The target lesion requiring interventional treatment is confirmed coronary chronic total occlusion (CTO); (3) Agree to enroll in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Admitted to the hospital with a diagnosis of acute ST-elevation myocardial infarction; 2.Patients with heart failure and respiratory failure who are unable to lie flat; 3.History of contrast allergy; 4.Acute and chronic infectious diseases (severe pneumonia, etc.); 5.Recent history of hemorrhagic stroke (within half a year); 6.Severe liver (total bilirubin >3ULN) and renal insufficiency (EGFR<15ml/min/1.73m^2) caused by various reasons; 7.History of various cardiomyopathy; 8.Severe anemia, thrombocytopenia and other hematologic diseases; 9.Patients with malignant tumors, autoimmune diseases, glucocorticoids and immunosuppressants for various reasons; 10.Pregnant women, lactating women, and patients with pregnancy plans during this trial. 11. Participation in other interventional clinical studies or those who, in the opinion of the investigator, are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Manipulation time;

Secondary

MeasureTime frame
Total surgery time;Surgical radiation dose;

Countries

China

Contacts

Public ContactHao Lu

Zhongshan Hospital, Fudan University

lu.hao@zs-hospital.sh.cn+86 21 6404 1990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026